#104: TEVA Pharmaceutical Stock News : Study Demonstrates That QVAR(R) is More Cost-Effective Than Other Inhaled Corticosteroid (ICS) Asthma Therapy Options
- Real-Life Study Shows the Cost-Effectiveness of QVAR(R) vs. CFC-Beclomethasone and Fluticasone -Sep. 16, 2009 (PR Newswire) --VIENNA, Sept. 16 /PRNewswire/ -- Teva Respiratory, a division of Teva...
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that
further to its press release dated July 1, 2009, Teva and Ortho McNeil
Janssen have agreed to cease...
PreCISe Data Presented at World Congress on Treatment and Research in
Multiple Sclerosis
New data from PreCISe, in clinically isolated syndrome patients, have
...
-Teva Gains a Strong Platform to Become a Leading Player in Spain-
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that
it has completed its...
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced today that the U.S. District Court for the District of New Jersey has issued a decision in its...
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted approval for the Company’s...
JERUSALEM, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted approval for the...
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) today announced the Office of the Chief Executive Officer, which will now include George Barrett,...
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that it will continue to sell its generic version of OxyContin® tablets at least...
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that it has reached an agreement with Biovail Corporation regarding Bupropion...
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVA) announced today that the U.S. Food and Drug Administration has granted approval for the Company's...
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted final approval for the...
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today reported results for the quarter and the full year ended December 31, 2006. Net sales for the...
JERUSALEM, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced today that
it has commercially shipped Bupropion Hydrochloride Extended-Release ...
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that
the U.S. Food and Drug Administration has granted tentative approval for
the...